EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

C1q neutralization during epileptogenesis attenuates complement‐mediated synaptic elimination and epileptiform activity

Yoonyi Jeong iD, Hyun-Kyoung Lim iD, Hayeon Kim iD, Juheon Lee iD, Siyoon Lee iD, Minah Suh iD

Epilepsia · 2026

DOI: 10.1111/epi.18678 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, 2026. Verfasst von Yoonyi Jeong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Sungkyunkwan University, Suwon, Republic of Korea. Hauptthemen laut MEDLINE: Complement C1q, Status Epilepticus, Synapses, Epilepsy. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Research Foundation of Korea, Institute for Basic Science, the Fourth Stage of the Brain Korea 21 Project in the Department of Intelligent Precision Healthcare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Accumulating evidence indicates that aberrant C1q‐C3 complement signaling in microglia and astrocytes drives synaptic dysfunction and neuronal loss. C1q‐mediated synaptic dysfunction disrupts neuronal circuitry balance and can lead to network hyperexcitability in epilepsy. However, the therapeutic potential of C1q inhibition remains unclear. This study aimed to delineate whether blocking C1q‐driven pathways at critical times can effectively prevent further synaptic loss and attenuate epileptiform activity in a mouse model of epilepsy.

Methods

Microglial C1q and astrocytic C3 expression was examined in hippocampal CA1 and CA3 regions at acute (1 day), subacute (7, 14 days), and chronic (5 weeks) phases following pilocarpine‐induced status epilepticus (SE) in mice. To evaluate the role of C1q activation, a C1q‐neutralizing antibody or isotype control immunoglobulin G antibody was administered into cisterna magna at 7 days post‐SE. During the chronic phase, glial reactivity, dendritic spine density, and epileptiform activity were assessed by immunostaining, Golgi staining, and electroencephalography (EEG) recording. After exclusions, 58 mice were included in the study.

Results

C1q expression was elevated during the subacute phase (7 and 14 days post‐SE) in CA1 and CA3 regions; astrocytic C3 expression increased in CA1 and persisted chronically. C1q‐neutralizing antibody administration at 7 days post‐SE, a time point characterized by prominent C1q upregulation, attenuated microglial synaptic phagocytosis, and astrocytic C3 activation. This intervention preserved dendritic spine density and ultimately reduced interictal spike frequency in EEG recordings in the chronic phase. Significance Our findings demonstrate that C1q acts as an upstream mediator of complement‐driven neuronal loss during epileptogenesis. C1q blockade interrupted the pathogenic cascade involving microglial engulfment and astrocytic C3 upregulation, thereby preserving synaptic and neuronal integrity and reducing interictal spike activity. Our study highlights the therapeutic potential of C1q inhibition, which can provide multifaceted benefits by mitigating neuroinflammation, improving synaptic integrity, and reducing epileptiform activity during epileptogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Complement C1qStatus EpilepticusSynapsesEpilepsyAntibodies, NeutralizingAnimalsMiceAstrocytesMicrogliaMalePilocarpineMice, Inbred C57BLElectroencephalographyDisease Models, AnimalHippocampusComplement C3

Stichwörter der Autor:innen

C1qdendritic spinesepileptogenesismicrogliaphagocytosis

Substanzen

Complement C1qPilocarpineComplement C3Antibodies, Neutralizing

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Sungkyunkwan University, Suwon, Republic of Korea.
  • Center for Neuroscience Imaging Research, Institute for Basic Science, Suwon, Republic of Korea.
  • Department of Intelligent Precision Healthcare Convergence, Sungkyunkwan University, Suwon, Republic of Korea.
  • Biomedical Institute for Convergence at SKKU, Sungkyunkwan University, Suwon, Republic of Korea.
  • KIST-SKKU Brain Research Center, Sungkyunkwan University, Suwon, Republic of Korea.
  • IMNEWRUN, Suwon, Republic of Korea.

ORCID-Profile: Yoonyi Jeong, Hyun-Kyoung Lim, Hayeon Kim, Juheon Lee, Siyoon Lee, Minah Suh

Förderung

  • National Research Foundation of Korea
  • Institute for Basic Science
  • the Fourth Stage of the Brain Korea 21 Project in the Department of Intelligent Precision Healthcare
  • Institute of Information & Communications Technology Planning & Evaluation

Zitieren

APA

Jeong, Y., Lim, H. K., Kim, H., Lee, J., Lee, S., & Suh, M. (2026). C1q neutralization during epileptogenesis attenuates complement‐mediated synaptic elimination and epileptiform activity. Epilepsia. https://doi.org/10.1111/epi.18678

Vancouver

Jeong Y, Lim HK, Kim H, Lee J, Lee S, Suh M. C1q neutralization during epileptogenesis attenuates complement‐mediated synaptic elimination and epileptiform activity. Epilepsia. 2026. doi:10.1111/epi.18678

BibTeX
@article{Jeong2026,
  author = {Jeong, Yoonyi and Lim, Hyun-Kyoung and Kim, Hayeon and Lee, Juheon and Lee, Siyoon and Suh, Minah},
  title = {C1q neutralization during epileptogenesis attenuates complement‐mediated synaptic elimination and epileptiform activity},
  journal = {Epilepsia},
  year = {2026},
  doi = {10.1111/epi.18678}
}
Kostenlos starten →